Dr. Jason Karlawish will be moderating the Alzheimer's Clinical Trials Consortium event discussing Amyloid PET as a suitable surrogate endpoint for clinically meaningful outcomes.
Back to All Events
Earlier Event: February 17
Divisional Spotlight for Research
Later Event: March 1
The Dubin Center Symposium: Innovations in Alzheimer's Caregiving and Treatment